Mabtas 100 Mg Injection

Product Description

Product introduction

Mabtas T 100mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Mabtas T 100mg Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.

Before taking it, tell your doctor if you have heart disease, liver, or planning surgery or vaccination or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Precise Targeting for Cancer and Autoimmune Diseases

Mabtas delivers rituximab, a monoclonal antibody, directly into the bloodstream, targeting specific cancer or immune cells. Its unique action helps to improve outcomes for conditions like Non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. Designed for adult patients, Mabtas enhances treatment precision, allowing for more controlled management of difficult-to-treat illnesses.


Instructions and Safe Administration

This medication is strictly administered as an intravenous (IV) injection by healthcare professionals in clinical settings. Precise dosages and schedules are determined by the prescribing physician according to the patient's condition and response. Because it is a potent biological drug, it is essential that Mabtas is always used under appropriate medical supervision to monitor for side effects and effectiveness.


Essential Storage and Handling Guidelines

To maintain Mabtas' efficacy, it must be stored in a refrigerator at 2C to 8C, away from direct light. Freezing and improper handling can reduce the medication's effectiveness. Always ensure the solution appears clear or slightly opalescent and colorless to pale yellow before use, and follow expiry and shelf life guidance as provided on the packaging.